Existing Drugs Being Examined as Fibromyalgia Treatment: PAINWeekBy Kristina R. AndersonLAS VEGAS. NV -- September 11. 2007 -- Four new drugs have been undergoing trials for potential use as treatments for fibromyalgia including one that is better known as the "go out rape" medicate a rheumatologist reported here at PAINWeek 2007 the national conference on hurt for frontline practitioners. Sodium oxybate (Xyrem®) also known as gamma hydroxybutyrate which due to safety concerns is currently approved for use only in small populations for the treatment of cataplexy and narcolepsy is designed to plow users straight from stage 2 sleep into the deeper re-create 4 rest that fibromyalgia patients generally are unable to attain on their own."Improving stage 4 rest is a very intriguing idea," said Andrew J. Holman. MD. Assistant Clinical Professor Medicine. University of Washington and Rheumatologist. Valley Medical Center. Seattle. Washington. United States. Designs for arrange 3 trials for sodium oxybate are now underway he said. Previous trials using liquid dosages of 4.5 g and 6 g indicated a statistically improvement of 20% or greater in a unique composite result that used three factors -- the patients' Pain-Visual Analog measure the Fibromyalgia force Questionnaire and the Patient Global Impression of dress -- rather than a single ranking. Dr. Holman told the audience that more than 20% of patients in these trials reported an overall improvement of 50%. Also well downstream in the approval pipeline are products that were originally designed for other conditions including Parkinson's disease restless leg syndrome and depression he said. Duloxetine (Cymbalta) primarily targets major depression disorder and has recently been submitted to the Food and Drug Administration for review as a treatment for fibromyalgia. The drug acts on both norepinephrine and serotonin receptors similar to the old class of tricyclic antidepressants although data released this summer at the 2007 World Congress on Myofascial hurt Syndrome and Fibromyalgia Syndrome reported improvement in fibromyalgia symptoms in patients with and without depression. Although there was no improvement in the 10 men in that 207-patient chew over. Dr. Holman predicted that duloxetine would be the next medication to acquire FDA approval for fibromyalgia. "I'm confident it is a useful medication and will back up people," he said. Another antidepressant in phase 3 trials for fibromyalgia is milnacipran which inhibits norepinephrine and serotonin reuptake in a 3:1 ratio; the preliminary results of the back up phase 3 multicentre trial were announced in May by Forest Pharmaceuticals and Cypress Bioscience who had enrolled some 1,200 patients with fibromyalgia. They showed significant statistical improvement with symptoms of fibromyalgia and associated hurt at dosages of 200 mg compared with placebo. Finally. Pramipexole (Mirapex® and Sifrol®) is currently a medication indicated for treating Parkinson's disease and restless leg syndrome and is sometimes also used off-label for treatment of certain types of headache. The drug affects the hippocampus and is also seen as aiding users in reaching that highly coveted re-create 4 of rest. Dr. Holman said the drug is appealing for fibromyalgia symptoms due to the relatively low incidence of nausea and dizziness as well as its renal metabolism characteristics. He also pointed out to the audience that Pramipexole led to the loss of 2 to 15 kg (5 to 35 lbs) over 14 weeks in 40% of the test subjects. He called the charge loss an indication that patients with fibromyalgia in command are not exaggerating in describing their oftentimes baffling symptoms to the primary care doctors. "People who express you they've gained charge are telling the truth," he said. Physicians have in their bag of tricks for fibromyalgia the drug Pregabalin (Lyrica®) which is already approved for this indication. The anticonvulsant commonly used for neuropathic pain is given at doses of 450 mg/day and has produced improved scores in rest fatigue and the Patient Global Impression of Change he said.[Presentation call: Treatment and Management of Pain Associated With Fibromyalgia.] All contents Copyright (c) 1995-2007 adulterate's command Publishing Limited. All rights reserved f: Existing Drugs Being Examined as Fibromyalgia Treatment: PAINWeek
Wonderful news for a fibromyalgia sufferers. Restorative sleep is so very important when dealing with constant hurt.
Wonderful news for a fibromyalgia sufferers. Restorative sleep is so very important when dealing with constant pain.
pfizer and forest are going to have a fibro medicate! desire everything else in the pharma world once one does something everyone ordain go unfortunately there is nothing too unique out there!
pfizer and forest are going to undergo a fibro drug! like everything else in the pharma world once one does something everyone ordain follow unfortunately there is nothing too unique out there!
You.
Forex Groups - Tips on Trading
Related article:
http://www.cafepharma.com/boards/showthread.php?t=226239
comments | Add comment | Report as Spam
|
